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both transcription factors was observed only in MN (r  0.7,Tubular NF-B and AP-1 activation in human proteinuric re-
P  0.004). Patients with progressive MN had an overexpres-nal disease.
sion of MCP-1, RANTES, OPN, and TGF-, mainly in theBackground. Nuclear factor-B (NF-B) and activated pro-
proximal tubules, while no significant expression was found intein-1 (AP-1) are transcription factors that regulate many genes
MCD patients.involved in the progression of renal disease. Recent data have
Conclusions. On the whole, our results show that a tubularshown that NF-B is activated in tubules and glomeruli in
overactivation of NF-B and AP-1 and a simultaneous up-various experimental models of renal injury. In vitro studies
regulation of certain proinflammatory and profibrogenic genesalso suggest that proteinuria could be an important NF-B
are markers of progressive renal disease in humans. Increasedactivator. We therefore approached the idea that NF-B may
activation of solely NF-B and/or AP-1 may merely indicatebe an indicator of renal damage progression.
the response of tubular renal cells to injury.Methods. Paraffin-embedded renal biopsy specimens from
34 patients with intense proteinuria [14 with minimal change
disease (MCD) and 20 with idiopathic membranous nephropa-
thy (MN)] and from 7 patients with minimal or no proteinuria There is growing evidence that abnormal glomerular
(IgA nephropathy) were studied by Southwestern histochemis-
permeability to proteins causes proximal tubular cell dys-try for the in situ detection of activated transcription factors
function [1], and that proteinuria elicits tubular activa-NF-B and AP-1. In addition, by immunohistochemistry, we
performed staining for the NF-B subunits (p50 and p65) and tion associated with transcription factor activation [2]
AP-1 subunits (c-fos, c-jun). By immunohistochemistry and/or and overexpression of chemokines [3–6] and fibrogenic
in situ hybridization, the expression of some chemokines cytokines [3, 7].
[monocyte chemoattractant protein-1 (MCP-1), RANTES, os-
Transcription factors such as nuclear factor-B (NF-B)teopontin (OPN)] and profibrogenic cytokines [transforming
and activated protein-1 (AP-1) regulate the gene expres-growth factor- (TGF-)], whose genes are regulated by
NF-B and/or AP-1, were studied further. sion of several cytokines, chemotactic and matrix pro-
Results. NF-B was detected mainly in the tubules of pro- teins that are involved in inflammation, immunologic
teinuric patients, but rarely in nonproteinuric IgA nephropathy responses, and cell proliferation [8–12]. Recent data have
(IgAN) patients. In addition, there was a significant relation-
shown that NF-B is activated in tubules and glomeruliship between the intensity of proteinuria and NF-B activation
in various experimental models of renal injury. Thus,in MCD (r  0.64, P  0.01) and MN patients (r  0.64, P 
0.01). Unexpectedly, patients with MCD had a significantly rats with protein-overload proteinuria, a model with in-
higher NF-B tubular activation than those with MN (P  terstitial inflammation and tubular up-regulation of mono-
0.01). To assess whether there was a different composition of cyte chemoattractant protein-1 (MCP-1) and osteopontin
NF-B protein components, immunostaining was performed
(OPN) [3, 13], present NF-B activation in tubules [2].for the NF-B subunits p50 and p65. However, no differences
Furthermore, in adriamycin-induced nephrosis, activa-were noted between MCD and MN patients. In those patients,
there was a lower tubular activation of AP-1 compared with tion of NF-B in renal cortex has been shown by electro-
NF-B. Moreover, a strong correlation in the expression of phoretic mobility shift assay (EMSA) [14].
We therefore addressed the idea that NF-B could
be an indicator of renal damage progression in humanKey words: nuclear factor-B, activator protein-1, monocyte chemo-
proteinuric nephropathies. We studied the in situ expres-attractant protein-1, transforming growth factor-, osteopontin, mini-
mal change disease, membranous nephropathy. sion of activated transcription factors NF-B and AP-1
by using Southwestern histochemistry (SWH), and ana-Received for publication October 3, 2000
lyzed their correlation with the expression of MCP-1,and in revised form May 14, 2001
Accepted for publication May 16, 2001 RANTES, OPN, and transforming growth factor-
(TGF-) in renal biopsy sections of patients with mini- 2001 by the International Society of Nephrology
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mal change disease (MCD) and idiopathic membranous Kidney sections were cut in 4-m thick pieces, de-
waxed in xylene, and rehydrated. Then the preparationsnephropathy (MN).
were incubated with 5 mmol/L levamisole (Sigma Chemi-
cal Co., St. Louis, MO, USA) to quench endogenous
METHODS alkaline phosphatase and were fixed with 0.2% p-formal-
Human kidney specimens dehyde for 30 minutes at 28C. Preparations were then
digested with 0.5% pepsin A (433 U/mg; Sigma ChemicalKidney samples were obtained by percutaneous renal
Co.) in 1 N HCl for 30 minutes at 37C and washed twicebiopsy from patients undergoing diagnostic evaluation
with buffer 1 [10 mmol/L HEPES, 40 mmol/L NaCl, 10at the Division of Nephrology (Austral University, Val-
mm MgCl2, 1 mmol/L dithiothreitol (DTT), 1 mmol/Ldivia, Chile). The renal biopsies from 34 patients with
ethylenediaminetetraacetic acid (EDTA), and 0.25%intense proteinuria (14 with MCD and 20 with MN) were
bovine serum albumin (BSA), pH 7.4]. Next, sectionsstudied and compared with those from 7 patients with
were incubated with 0.1 mg/mL DNAse I in buffer 1 forIgA nephropathy with minimal or no proteinuria. The
30 minutes at 30C and were washed once with buffer 2biopsies in children with nephrotic syndrome were per-
(buffer 1 with 10 mmol/L EDTA instead of MgCl2) toformed in those having two or more relapses. Control
end the reaction. Finally, they were exposed during threehuman kidney specimens (N  5) were taken from nor-
minutes to decreasing alcohol gradients (70, 90, andmal portions of renal tissue from patients who underwent
100%). The labeled probe was diluted in buffer 1 con-surgery because of localized renal tumors. The diagnosis
taining 0.5 mg/mL poly (dI-dC) (Pharmacia LKB, Pisca-of MCD, MN, and IgA nephropathy (IgAN) was made
taway, NJ, USA) at an empirically established concentra-based on clinical and histological findings. Standard stud-
tion (100 pmol/L), and then 100 L of this solution wereies were done to exclude secondary causes of MN.
applied per slide overnight at 37C in a humidified box.The classification of progressive MN was done in 11
Sections were washed twice with buffer 1, washingout of 20 MN patients, based on the presence of severe
buffer (0.03% Tween 20 in buffer 1, consisting of 0.1nephrotic syndrome (proteinuria 8 g/day, for at least
mol/L maleic acid, 0.15 mol/L NaCl, pH 7.5), and werefor 6 months), interstitial cell infiltration, and decrease
then incubated for one hour in blocking solution [0.1 of renal function at the time of the biopsy (cases 10, 12,
standard sodium citrate (SSC), 0.1% sodium dodecyl15, 16, 17, 18, 19, and 20), or during the following months
sulfate (SDS) diluted 1:10 in washing buffer]. The prepa-(cases 11, 13, and 14). The nine nonprogressive MN
rations were washed once more in washing buffer andpatients were also nephrotic (proteinuria 3 g/day, for
incubated with an antidigoxigenin antibody conjugatedless than 6 months), but without interstitial cell infiltra-
with alkaline phosphatase (1:250 in blocking solution;
tion, and had a stable renal function at the time of biopsy Boehringer Mannheim) overnight at 4C. Next, sections
and during the long-term follow-up. were washed in washing buffer and in buffer 3 (Tris-HCl
All patients were without treatment at the time of the 0.1 mol/L, 0.1 mol/L NaCl, 50 mmol/L MgCl2, pH 9.5) atbiopsy, and none of them had renal vein thrombosis. room temperature. Alkaline phosphatase was visualized
Histological diagnosis was made by light, fluorescence, with nitroblue tetrazolium chloride and 5-bromo-4-
and electron microscopy. For light microscopy, kidney chloro-3-indolyl-phosphate (NBT/BCIP; Dako, Carpin-
tissues were fixed in 4% buffered formalin, dehydrated, teria, CA, USA). Color was allowed to develop in the
and embedded in paraffin by conventional techniques. dark at 37C for one hour or until a visible precipitate
Sections were stained with hematoxylin and eosin (HE), was developed. The reaction was stopped by incubation
periodic acid-Schiff (PAS), and silver methenamine. in TE buffer (10 mmol/L Tris 1 mmol/L EDTA, pH 8.0),
and sections were dehydrated in ethanol series andSouthwestern histochemistry
mounted in Canadian balsam (Polysciences Inc., War-
The Southwestern histochemistry (SWH) technique has rington, PA, USA).
been described in detail recently by Herna´ndez-Presa, As negative controls, the following were used: (1) ab-
Go´mez Guerrero, and Egido [15]. sence of probe; (2) mutant NF-B probe (sense 5	-AGT
Synthetic sense DNA 5	-AGTTGAGGGGACTTT TGAGGCTCCTTTCCCAGGC-3	), and mutant AP-1
CCCAGGC-3	, which contains a consensus sequence of (sense 5	-CGCTTGATGAGTTGGCCGGAA-3	) probe,
NF-B, and synthetic sense DNA 5	-CGCTTGATGA labeled with digoxigenin, at the same concentration as
GTCAGCCGGAA-3	 (GIBCO BRL, Life Technology, the respective labeled probe; and (3) competition assays
Gaithersburg, MD, USA), which contains a consensus with a 200-fold excess of unlabeled NF-B and AP-1,
sequence of AP-1, were used as the probes. After anneal- followed by incubation with labeled probe.
ing with their complementary DNA (80C during 2 min-
Immunohistochemistryutes), each probe was labeled with digoxigenin (DIG
oligonucleotide 3-end labeling kit; Boehringer Mannheim, Paraffin-embedded biopsy specimens were used to de-
tect NF-B p50, NF-B p65, AP-1 c-fos, AP-1 c-jun,Mannheim, Germany).
Mezzano et al: Tubular NF-jB and AP-1 activation1368
MCP-1, RANTES, and OPN. Specific biotinylated sec- Slide-mounted sections were treated with 2  SSC (SSC
1  0.15 mol/L NaCl in 0.015 mol/L trisodium citrate,ondary antibodies, followed by streptavidin-horseradish
peroxidase conjugate (Dako) and revealed with DAB, pH 7) at 60C for 10 minutes and were washed with
DEPC-treated water.were used.
The following primary antibodies were employed: The tissue sections were digested with proteinase K
(5 g/mL in 0.05 mol/L Tris, pH 7.6) for 60 minutes atanti–NF-B p50 (goat polyclonal IgG, sc-1191; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), anti–NF-B 37C. After a wash with DEPC-treated water, the sec-
tions were incubated with a prehybridization solutionp65 (mouse monoclonal, cat. 1697838; Boehringer Mann-
heim), anti–c-jun (H-79, rabbit polyclonal IgG, sc-1694; (Dako mRNA In Situ Hybridization Solution) for 60
minutes at 37C. The hybridization reaction was per-Santa Cruz), anti–c-fos (K-25, goat polyclonal IgG, sc-
253-G; Santa Cruz), anti–MCP-1 (goat polyclonal IgG, formed overnight at 37C with 100 L of biotin-labeled
probe cocktails for each cytokine (200 ng/mL; R&D Sys-AB-279-NA; R&D Systems, Minneapolis, MN, USA),
anti-RANTES (goat polyclonal, AB-278-NA; R&D Sys- tems) in a humidified chamber.
Then the slides were washed twice with 4  SSC 30%tems), anti-OPN (mouse monoclonal, MPIIIB10; DSHB).
Briefly, 5- thick renal sections, Bouin- or formalin-fixed formamide, 2  SSC 30% formamide, and 0.2  SSC
30% formamide at 37C for 5 minutes and then with 1 and paraffin-embedded, were adhered to polylisine-cov-
ered glass and fixed overnight at 56C. After deparaffin- Tris-buffered saline (TBS) containing 2% Triton at room
temperature for 15 minutes.izing through xylene, alcohol, and distilled water, endoge-
nous peroxidase was blocked by 3% H2O2 for 20 minutes. Detection was performed with avidin-alkaline phos-
phatase conjugate (Dako) for 30 minutes at room tem-The sections were then treated in a microwave oven in
a solution of 0.1 mmol/L citrate buffer, pH 6.0, for 20 perature, washed for 5 minutes with 1TBS using NBT-
BCIP as the enzyme substrate for 120 minutes at 37Cminutes and transferred to distilled water. After rinsing
in Tris-HCl-phosphate-buffered saline (TPS), the sections in the dark (R&D Systems) or fuchsin and naphtol-phos-
phate for 20 minutes at room temperature (Dako). Tis-were incubated with 1:10 normal rabbit serum in TPS/1%
BSA. The sections were then incubated overnight at sues were then dehydrated in ethanol series and mounted
in Canadian balsam (Polysciences Inc.).4C with unlabeled polyclonal and monoclonal specific
primary antibodies. For the NF-B p65 and OPN stain- The specificity of the reaction was confirmed by (1)
demonstrating the disappearance of hybridization signaling, after three rinses in TPS, the sections were incubated
with biotinylated rabbit anti-mouse in a 1/200 dilution when RNAse (100 g/mL; Sigma Chemical Co.) was
added in 0.05 mol/L Tris after the digestion with protein-in TPS-1% BSA. For detection of NF-B p50, c-fos,
MCP-1, and RANTES, the sections were incubated with ase K; (2) by the use of a sense probe (R&D Systems);
(3) with a negative control (plasmid DNA; Dako); andbiotinylated rabbit anti-goat, dilution 1/100 in TPS-1%
BSA for 30 minutes at 22C. To detect c-jun, the sections (4) without probe.
were incubated with biotinylated swine anti-rabbit, dilu-
Southwestern histochemistry coupled totion 1/100 in TPS-1% BSA for 30 minutes at 22C. After
in situ hybridizationthree rinses in TPS, they were incubated with streptavidin-
peroxidase (Dako) 1/500 for 30 minutes. Color was devel- This technique was performed to detect simultane-
ously the NF-B–positive cells by SWH and cells express-oped with diaminobenzidine, was then counterstained
with hematoxylin, and was dehydrated and mounted with ing mRNA MCP-1 or mRNA RANTES by ISH on the
same biopsy section. Renal sections 5  thick, fixed inCanadian balsam (Polysciences, Inc.). The specificity was
checked by omission of primary antibodies and use of 4% buffered formalin and embedded in paraffin, were
sequentially treated for ISH and SWH as reported pre-nonimmune sera.
viously in this article.
In situ hybridization
Immunohistochemical quantificationThe in situ hybridization (ISH) method has been de-
scribed previously [16]. Biotin-labeled human MCP-1, The labeled surface area was evaluated by quantitative
image analysis using a KZ 300 imaging system 3.0 (Zeiss,RANTES, and TGF- probes were purchased from
R&D Systems. Mu¨nchen-Hallbergmoos, Germany). Briefly, the per-
centage of the stained area was calculated as the ratioTissue was fixed in 4% buffered formalin, embedded
in paraffin wax, and cut into 5-m sections, which were of suitable binary thresholded image and the total field
area. For each sample, the mean staining area was ob-mounted onto 3-aminopropyltriethoxy-silane–coated slides
treated with diethylpyrocarbonate (DEPC; Sigma Chemi- tained by analysis of 20 different fields (40), excluding
glomeruli and vessels. Quantification was done twice,cals Co.)
Tissue sections were dewaxed with xylene and rehy- independently, and interassay variations were not sig-
nificant. The staining score is expressed as density/mm2.drated through a series of decreasing ethanol solutions.
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Table 1. Clinical data of patients with minimal change disease (MCD)
Serum Proteinuria
creatinine g/day/ MAP NF-B score
Case Sex Age mg/dL 1.73 m2 mm Hg density/mm2
1 F 2 0.5 12 73 16,854
2 F 3 0.4 15 80 18,035
3 F 3 0.3 6 70 3,886
4 F 3 0.8 16 77 22,057
5 M 3 0.4 7 70 12,092
6 F 5 0.4 4 70 1,984
7 F 7 0.5 16 87 5,589
8 M 10 0.6 7 90 9,933
9 F 16 1.0 7 90 11,881
10 F 16 1.6 8 90 6,178
11 M 25 1.1 8 100 27,992
12 M 29 1.8 9 97 13,073
13 F 40 1.0 24 110 44,872
14 M 44 1.0 12 93 20,353
Mean 15
14 0.81
0.5 11
5 86
13 15,341
3,017
Abbreviations are: MAP, mean arterial pressure; NF-B, nuclear factor-B
staining score.Fig. 1. In situ detection of activated nuclear factor-B (NF-B) in
human glomerulopathies [Southwestern histochemistry (SWH); com-
puter image analysis and expressed as density/mm2]. Tubular NF-B
was significantly more elevated in patients with proteinuria [minimal
change disease (MCD) and idiopathic membranous nephropathy (MN)]
patients with IgAN was similar to that of normal controlthan in nonproteinuric patients (IgAN) and in normal subjects (P 
0.05, Kruskal-Wallis). kidneys (P  0.05).
Table 1 summarizes the clinical data and the renal
staining score of NF-B activation in each patient with
MCD. All patients were nephrotic at the time of the
Statistical analysis biopsy and had normal renal function and normal blood
The statistical analysis was performed with the Instat, pressure. In these patients, there was a strong correlation
GraphPad Software (San Diego, CA, USA). The results between proteinuria (expressed as g/24 h/1.73 m2) and
of the clinical data are expressed as the mean 
 SD. the staining score for activated NF-B (r  0.64, P 
The score for the intensity and distribution of staining 0.01; Fig. 2). Activated NF-B was detected mainly in
for the SWH, immunohistochemistry (IMH), and ISH cortical tubular epithelial cells and in a sparse manner
in the different groups of patients are expressed as the in some glomerular cells, mainly podocytes (Fig. 3A, B).
mean
 SEM. The comparison between groups was done The glomerular NF-B staining score also was signifi-
by Kruskal-Wallis test (nonparametric analysis of vari- cantly higher in patients with MCD than in patients with
ance), with Dunn’s multiple comparisons test. Other- MN (3707 
 1242 vs. 617
 190, P  0.007). In addition
wise, the Mann-Whitney U test for unpaired groups or to podocytes, some nuclei of parietal cells and endothe-
Wilcoxon for matched pairs was used. Spearman correla- lial cells were positive for activated NF-B.
tion was used to correlate the proteinuria with the tran- To define the localization of NF-B activation better,
scription factors tubular activation or to correlate the double staining with lectins was performed for proximal
expression of both transcription factors. The Fisher test (Tetragonolobus Purpureas biotin-labeled; Sigma L3134)
was used when appropriate. A P value of 0.05 was and distal tubules (Dolichos Biflorus biotin-labeled;
considered significant. Sigma L6533). The observed results (data not shown)
confirmed that NF-B activation mainly occurred in the
proximal tubules.RESULTS
Patients with MN were subdivided in progressive (11
Detection of renal NF-B by SWH in cases) and nonprogressive (9 cases; Table 2). There were
human glomerulopathies no significant differences in age, sex, and mean blood
As illustrated in Figure 1, both groups of proteinuric pressure between the two groups. Patients with progres-
sive renal disease had a significantly higher proteinuriapatients (MCD and MN) had a significantly higher
NF-B tubular activation than the nonproteinuric pa- (P 0.01), serum creatinine (P 0.01), and tubulointer-
stitial cell infiltration (P  0.01).tients (IgAN; P 0.05). Unexpectedly, the staining score
for activated NF-B was significantly higher in patients The staining score for NF-B activation was signifi-
cantly higher in patients with a progressive versus non-with MCD than in patients with MN (15,341 
 3017 vs.
6660 
 765, P  0.009). On the other hand, the staining progressive disease (8529 
 1016 vs. 4375 
 572, P 
0.01), and the entire group had a significantly higherscore for NF-B tubular activation in the renal tissue of
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components, also was detected by SWH in those patients.
As illustrated in Figure 5, the proteinuric nephropathies
(MCD and MN) had a significantly higher AP-1 tubular
activation in relationship to the nonproteinuric IgAN
patients and controls (P  0.05). In MCD patients, AP-1
activation was detected mainly in tubular epithelial cells
(Fig. 3C). However, the staining score for AP-1 was
significantly lower in relation to NF-B activation (P 
0.002). AP-1 tubular activation was not correlated with
the magnitude of proteinuria in MCD patients. In addi-
tion, there was not a significant Spearman’s correlation
between the activation of both transcription factors in
MCD patients (Fig. 6).
Figure 4C shows that AP-1 activation was observed
in patients with MN. This transcription factor was mainly
detected in cortical tubular epithelial cells of MN pa-
tients with progressive disease. However, the presence
of this activated transcription factor was correlated with
the magnitude of proteinuria (P 0.05), and in addition,
there was a strong Spearman correlation between NF-B
and AP-1 tubular activation in these patients (r  0.7,
P  0.004; Fig. 6).
Detection of proinflammatory chemokines in MCD
and MN by IMH and ISH
As NF-B and AP-1 promote the expression of a num-
ber of genes involved in inflammation, such as cytokines
and chemotactic proteins, we studied the expression of
some proinflammatory chemokines (MCP-1, RANTES,
and OPN) in the renal tissue of these patients. As pre-
Fig. 2. Spearman correlation between the magnitude of proteinuria viously reported, by ISH there was a significant up-regu-
(g/day) and tubular NF-B activation (SWH) in nephrotic patients with
lation of these chemokines, found mainly in tubular epi-MCD (A; r  0.64, P  0.01) and MN (B; r  0.64, P  0.002).
thelial cells of MN patients, with a marked correlation
between the MCP-1 and RANTES mRNA expression
and with a stronger expression in those with a progressive
tubular NF-B activation than the nonproteinuric IgAN disease (mRNA MCP-1 staining score was 25,689
 7943
patients and controls (P  0.05), but it was significantly in progressive vs. 3329 
 2056 in nonprogressive MN,
lower than patients with MCD (P  0.009; Fig. 1). P  0.05; Figs. 4E and 7E) [16]. We did not detect
The activated NF-B was mainly observed in cortical mRNA MCP-1 or RANTES expression in MCD patients
tubular epithelial cells and, to a lesser extent, in some (Fig. 3E). In the glomeruli, there was no mRNA up-
glomerular (mainly podocytes) and interstitial cells. (Fig. regulation of these proinflammatory cytokines, but in
4A, B). Using a computer image analysis, we segmented some MN patients, a mild glomerular immunostaining
the interstitial area in patients with progressive MN, for MCP-1 and RANTES was observed.
counting the NF-B positive nuclei, and found a staining In addition, IMH was used to study the expression of
score of 8971 
 3198, mainly corresponding to mononu- these proteins using specific polyclonal antibodies. MCP-1
clear cells. and RANTES protein expression, almost absent in nor-
In patients with MN, there was also a significant corre- mal renal tissue and MCD, was detected mainly in epi-
lation between the range of proteinuria and the staining thelial tubular cells of MN patients and had a stronger
score of NF-B tubular activation (r  0.64, P  0.002; immunostaining in those with progressive renal disease
Fig. 2). and with a pattern similar to that observed for their
respective mRNA values. The staining score for MCP-1
Detection of renal AP-1 by SWH in protein was significantly higher in MN (17,361 
 2587)
human glomerulopathies than in MCD patients (2311 
 999, P  0.005). The
The transcription factor AP-1, involved in the gene same occurred for RANTES protein (20,251 
 3778 in
MN vs. 1297 
 496 in MCD patients, P  0.005). Inregulation of some inflammatory proteins and matrix
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Fig. 3. Southwestern histochemistry (SWH) in patients with MCD. Activated NF-B (A and B) and AP-1 (C ) were mainly detected in cortical
tubular epithelial cells and, to a lesser extent, in some podocytes (case 11). Immunohistochemistry for the subunit NF-B p50 (D) and OPN (F ).
The p50 subunit was expressed mainly in cortical tubular epithelial cells. Staining for OPN was negative in tubular and glomerular cells. SWH for
NF-B coupled to ISH for MCP-1 (E ). Activated NF-B detected in nuclei of cortical tubular epithelial cells (blue color). No signal was seen in
the cytoplasm of these cells, hybridized with an anti-sense probe to MCP-1 (magnification 100).
some cases of MN, we observed a mild glomerular im- a stronger expression in patients with progressive MN
(Fig. 4F). The staining score for OPN was higher in MNmunostaining for the protein MCP-1, RANTES, and OPN
(this protein was only studied by IMH using a monoclonal (22,210 
 3936) than in MCD patients (3028 
 1449,
P  0.005). In the whole population of MN patients,antibody). The immunostaining of OPN was mainly de-
tected in tubular epithelial cells of MN patients, with a the staining score for MCP-1, RANTES, and OPN was
significantly associated with the staining score for NF-Bsimilar pattern to MCP-1 and RANTES, and again with
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Table 2. Clinical data of patients with membranous nephropathy (MN)
Serum creatinine Proteinuria MAP NF-B
Case Sex Age mg/L g/day mm Hg density mm2
Nonprogressive
1 F 12 0.6 5 80 1,691
2 M 38 1.2 9 103 6,861
3 F 39 0.9 7 97 4,895
4 M 42 0.9 5 93 5,141
5 M 50 1.0 5 103 2,543
6 M 50 1.2 7 103 2,906
7 F 52 0.7 4 97 4,929
8 M 65 1.0 5 100 4,164
9 M 68 1.3 6 93 6,250
Mean 46
16 0.97
0.2 5.8
1.5 96
7 4,375
572
Progressive
10 F 23 2.4 9 110 6,441
11 M 24 1.2 10 90 5,830
12 F 24 2.1 12 127 9,242
13 F 28 0.9 9 87 10,586
14 M 30 1.2 9 117 5,892
15 M 36 1.7 17 103 12,915
16 M 38 1.8 14 113 13,916
17 M 43 2.4 5 113 4,750
18 M 51 1.6 10 87 10,264
19 M 55 2.5 16 137 3,832
20 F 63 1.5 10 107 10,158
Mean 37
13 1.7
0.5 11
3.4 108
16 8,529
1,016
Abbreviations are: MAP, mean arterial pressure; NF-B, nuclear factor-B staining score.
tubular activation (P  0.05). Consistently, in biopsies MN, which might explain the differential expression of
their target genes, immunostaining for the NF-B sub-of patients with MCD, only sparse tubular and interstitial
staining for MCP-1, RANTES, and OPN was found by units p50 and p65 and AP-1 subunits c-fos and c-jun
was performed. The NF-B p50 and p-65 subunits wereIMH (Fig. 3F).
mainly detected in tubular epithelial cells (cytoplasm and
Expression of profibrogenic cytokine TGF- in MCD nuclei) of MCD and MN patients (Figs. 3D and 4D),
and MN patients without significant differences between the two groups
As TGF- is a target gene for AP-1 [17], we studied (Fig. 8).
its expression by ISH. TGF-was up-regulated mainly in When the expression of AP-1 subunits, c-fos and c-jun,
cortical tubular epithelial cells of MN patients (18,817 
 was studied in the MCD and MN biopsies, we also found
4280), and this expression was significantly higher in the a tubular staining pattern without significant differences
group with progressive (30,238 
 5451) versus nonpro- between these two groups of patients (Fig. 8).
gressive MN (7396 
 3942, P  0.01). In general, the
TGF- mRNA expression was increased in tubulointer-
DISCUSSIONstitial area, particularly in the proximal and distal tubules
This study shows NF-B activation in tubular epithe-surrounded by interstitial mononuclear cells, in accor-
lial cells of patients with MCD and MN, which is signifi-dance with the severity of the disease. Again, TGF-
cantly correlated with the magnitude of proteinuria. ThemRNA expression was not observed in the biopsies of
simultaneous up-regulation of certain proinflammatorypatients with MCD (1113 
 684).
(MCP-1, RANTES, OPN) and profibrogenic (TGF-b)
Detection of NF-B subunits p-50 and p-65, and AP-1 genes, observed in MN patients, but not in MCD, corre-
subunits c-fos and c-jun by immunohistochemistry lates with the disease progression. We suggest that a
in MCD and MN concomitant tubular overactivation of both NF-B and
AP-1, detected in MN but not in MCD, could explainThe activated form of NF-B is a heterodimer, which
the different transcription of these target genes. No dif-usually consists of two proteins, the p65 (also called relA)
ferences could be established in the composition ofsubunit and the p50 subunit. AP-1 is a dimeric transcrip-
NF-B or AP-1 subunits in both pathologies.tion factor composed of c-jun and c-fos subunits that
Our recent study showed that patients with humanbind to a common DNA site.
MN, mainly with progressive disease, have an overex-To determine whether there was a different composi-
tion of the NF-B and AP-1 components in MCD and pression of the chemokines MCP-1, RANTES, and OPN,
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Fig. 4. Activated NF-B and AP-1 in patients with MN (SWH). Activated NF-B (A and B) and AP-1 (C ) were mainly detected in tubular
epithelial cells and, to a lesser extent, in some glomerular cells and interstitial cells. Note an atrophic tubule with activated NF-B (case 15). IMH
for the subunit NF-B p50 (D) and OPN (F ). The p50 subunit was expressed mainly in cortical tubular epithelial cells. Strong tubular staining
for OPN was noted. ISH for MCP-1 (E ). Strong up-regulation of MCP-1 mRNA was detected in tubular epithelial cells (magnification 100).
and the profibrogenic cytokines, platelet-derived growth The results of the present study further support that
notion, in the sense that NF-B and AP-1 tubular activa-factor-BB (PDGF-BB) and TGF-, in tubular epithelial
cells [16]. These data supported the theory that the in- tion, together with the up-regulation of related genes,
could be markers of renal damage progression.creased trafficking of proteins through the tubular cells
could activate NF-B and, consequently, augment the Moreover, in progressive MN, double staining revealed
that the same tubular epithelial cells simultaneouslytubular expression of target genes associated with inter-
stitial cell infiltration and tubulointerstitial damage [1–6]. showed NF-B activation (by SWH) and the presence
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Fig. 5. In situ detection of activated protein-1 (AP-1) in human glomerul-
opathies (SWH ; computer image analysis and expressed as dens/mm2).
Tubular AP-1 was significantly more elevated in patients with protein-
uria (MCD and MN) than in nonproteinuric patients (IgAN) and in
normal subjects (P  0.05, Kruskal-Wallis).
of some proinflammatory genes (MCP-1 and RANTES
mRNA by ISH; Fig. 7E), suggesting that this transcrip-
tion factor is involved in the expression of these genes,
and supporting the concept that RANTES and MCP-1
are NF-B–dependent genes [6, 18].
The mechanisms by which proteinuria could cause in-
terstitial inflammation and fibrosis are still not fully un-
derstood. In several experimental models of renal injury,
characterized by heavy and sustained proteinuria, the
overexpression of chemokines such as MCP-1, RANTES,
and OPN [1] and the vasoactive peptides such as angio-
Fig. 6. Spearman correlation between NF-B and AP-1 tubular activa-
tensin II (Ang II) and endothelin (ET-1) [19] was demon- tion (SWH) in patients with MCD (A; r  0.1, P  NS) and MN (B;
r  0.7, P  0.004).strated in renal tissue. Furthermore, incubation of tubu-
lar epithelial cells with albumin in concentrations similar
to those found in the urine from patients with nephrotic
syndrome induced an increment in the NF-B activity and
[22], and it is possible that the relatively short period ofan up-regulation of proinflammatory molecules [6, 18].
intense proteinuria in patients with MCD could be anWhy do patients with MCD, with a similar or greater
explanation.NF-B and AP-1 activation, have no overexpression of
In addition, the cooperation between various transcrip-proinflammatory and profibrogenic cytokines? It is well
tion factors to activate a particular gene is well known.known that transcription factors have a pivotal role in
It has been recently described that OPN is a target generegulating gene expression through their ability to inter-
for Ets transcription factors that need the interactionact with specific DNA sequences (which are unique to
with AP-1 to activate that gene [23]. On the other hand,each transcription factor) in the promoter region of dif-
the human TGF- gene is a target gene for the transcrip-ferent genes. Transcription factors not only modulate
tion factor AP-1 [17, 24]. Interestingly, AP-1, in turn, isthe degree of gene expression, but also the specificity of
activated in response to growth factors of the TGF-the signal, which is determined in part by the presence
family [12]. Since NF-B and AP-1 are probably theor absence of a binding site in the promoter region of a
most ubiquitous transcription factors, their activationparticular target gene. As mentioned in this article, a
merely could indicate that the first signal to transcribelarge number of stimuli can activate NF-B and AP-1,
a particular series of genes has taken place, althoughalthough which one is necessary to effectively trigger the
other more specific transcription factors need to be acti-gene expression of a particular cytokine remains unknown
vated to finally trigger the transcription of these genes.[12, 20, 21]. Moreover, the time period for activated
The present study employed a novel method for thetranscription factors remaining bound to the DNA bind-
in situ detection of activated transcription factors [15], us-ing site of the gene promoter region seems to be a key
element to trigger the expression of a particular gene ing nonradioactive probes in paraffin wax-embedded re-
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Fig. 7. Controls of the Southwestern histochemistry (SWH) technique (NF-B). (A) Normal renal tissue (no signal was noted). (B) MCD (case
13; positive control). (C) Negative control using a mutant NF-B probe (case 13). (D) Negative control in a competition assay with a 200-fold
excess of unlabeled probe (case 13). (F ) SWH in a patient with IgA nephropathy. No or minimal staining was detected in tubular epithelial and
glomerular cells. SWH for NF-B coupled to ISH for MCP-1 in MN (E; case 13). Activated NF-B detected in nuclei of tubular epithelial cells
(blue color). MCP-1 mRNA was up-regulated in the cytoplasm of these cells, and hybridized with an anti-sense probe to MCP-1 (red color;
magnification 100).
nal tissues, which allowed a simultaneous visualization of (mainly mononuclear cells) showed NF-B and AP-1
activation. Interestingly, in patients with non-proteinuricthe cell type-specific localization of these nuclear factors.
In patients with nephrotic syndrome (MCD and MN), IgA nephropathy, NF-B activity was observed mainly
in glomerular mesangial and glomerular epithelial cells,NF-B and AP-1 activity was mainly detected in cortical
tubular epithelial cells and, to a lesser extent, in some in agreement with a previous report (abstract; Ashizawa
et al, J Am Soc Nephrol 10:95A, 1999).glomerular cells (mainly podocytes). In addition, in pa-
tients with progressive MN, some renal interstitial cells The activated form of NF-B is a heterodimer that
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tubular cells with Ang II and endothelin-1 (ET-1)-specific
receptor antagonists inhibited the albumin-induced NF-B
activity [2].
As proteinuria also can elicit the synthesis of Ang II
and ET-1 in the renal cortex [19] and Ang II participates
in mononuclear cell recruitment in experimental nephri-
tis through NF-B activation and MCP-1 synthesis [28],
Ang II-dependent NF-B activation has been proposed
as a mechanism by which persistent proteinuria may par-
ticipate in the progression of renal disease [19]. In this
regard, in some models of renal injury, the administra-
Fig. 8. Detection of NF-B subunits (p50, p65) and AP-1 subunits (c-fos, tion of an ACE inhibitor prevented proteinuria and the
c-jun) in MCD ( ) and MN ( ) patients using IMH. The NF-B and activation of NF-B [28, 29].AP-1 subunits were mainly detected in tubular epithelial cells of MCD
Nonselective proteinuria contains numerous toxic/and MN patients, without significant differences between the two groups
(P  0.05; Mann Whitney test). inflammatory systems that may promote the progression
of renal disease [1]. Although increased urinary secretion
of lipoproteins is often seen in various glomerular dis-
usually consists of two proteins, the p65 and p50 subunits. eases associated with nephrotic proteinuria, the role of
In unstimulated cells, NF-B is found in the cytoplasm atherogenic proteins in the development of tubulointer-
and is bound to IB, which prevents it from entering the stitial lesion is not well understood [30]. Oxidized low-
nucleus. When these cells are stimulated, specific kinases density lipoprotein (LDL) induces MCP-1 in murine prox-
phosphorylate IB causing its rapid degradation by the imal tubular epithelial cells through activation of NF-B
proteasome. The release of IB from NF-B results in (abstract; Odawara et al, J Am Soc Nephrol 10:557A,
the passage of NF-B to the nucleus, where it binds to 1999). Very low-density lipoprotein (VLDL) also activates
specific sequences in the promoter region of target genes NF-B in monocytic cells [31]. Therefore, one could spec-
[8–10, 20, 25]. The presence of homodimers such as p50/ ulate that NF-B and AP-1 activation observed in ne-
p50 or p65/p65 and other less known components also phrotic patients might be due, at least in part, to the
may occur. Although p65 seems to be a key element in increased urinary lipoprotein excretion.
the gene transcription, the role of other subunits is less Finally, since NF-B plays such a pivotal role in the
clear. For this reason, we studied whether a distinct renal pathophysiology of a variety of disorders, it is conceiv-
composition of NF-B components in the two diseases able that exogenous modulation of NF-B activation may
could explain the differences in gene expression. How- be used to devise new therapeutic approaches. In adria-
ever, although various NF-B complexes were noted in mycin-induced nephrosis, when rats were treated with an
both types of patients (p65/p50; P50/50; the p65/p50 be- NF-B inhibitor, there was a parallel reduction in NF-B
ing the most common), no significant differences could activation and an improvement in the score of intersti-
be established. tial damage [14]. In addition, by inhibiting the action of
Nuclear factor-B can be induced in a great variety of NF-B, using a synthetic decoy antisense oligodeoxy-
cells in response to many different stimuli such as the pro- nucleotide, it is possible to block the underlying inflam-
inflammatory cytokines tumor necrosis factor- (TNF-) matory response in crescentic glomerulonephritis [32].
and interleukin-1 (IL-1), activators of protein kinase During the last few years, a certain number of articles
C (PKC), oxidants, viruses, lipopolysaccharide and ultra- have suggested that the detection of NF-B in various
violet light [8–10, 20, 25]. On the other hand, at the time tissues (kidney, vessels, and synovium to name a few)
of the kidney biopsies, patients were not receiving any may be a sign of injury [8]. The data provided in our study
treatment known to abolish NF-B activation, such as clearly indicate that only the simultaneous presence of
steroids, immunosuppressive drugs, angiotensin-convert- activated NF-B and/or AP-1, as well as the overexpres-
ing enzyme (ACE) inhibitors, or statins [20]. sion of some genes regulated by these transcription fac-
Recently, angiotensin II (Ang II) has been added to tors, is suggestive of active renal injury. The overactiva-
the list of important molecules that activate NF-B. In tion of NF-B and/or AP-1 alone may merely suggest a
cultured vascular smooth muscle cells and monocytes, cell response to injury.
Ang II elicited NF-B activation and MCP-1 up-regula- Progressive MN appears to be a good human model of
tion [26]. In addition, it has been shown in cultured tubular progressive proteinuric renal disease where the tubular
epithelial cells that Ang II increases NF-B activity via protein traffic may induce activation of transcription fac-
the Ang II type 1 and 2 (AT1 and AT2) receptors [2], a tors and transcription of regulated genes, such as chemo-
finding consistent with that observed in vascular smooth kines and profibrogenic factors, involved in renal disease
progression.muscle cells [27]. On the other hand, preincubation of
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